Home › Funds › Caligan Partners LP › IRD

Caligan Partners LP position in IRD

OPUS GENETICS INC · Health Care

Caligan Partners LP reported holding 6,077,084 shares of IRD (OPUS GENETICS INC) in its Q2 2026 13F filing — a position valued at US$25.0M, representing 1.46% of its reported portfolio and ranking #17 among its reported holdings. Caligan Partners LP has disclosed IRD holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)6.08M sh
Reported value held$24.98M
Portfolio Weight1.46%
First reportedQ1 2026
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Caligan Partners LP's IRD position evolved

Caligan Partners LP first disclosed a stake in IRD in Q1 2026 at 6,075,028 shares (US$27.6M). Across 2 filings, Caligan Partners LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 6,077,084 shares valued at US$25.0M.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 6.08M $27.64M New
Q2 2026 6.08M $24.98M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IRD and 13F data

IRD (OPUS GENETICS INC) is a Health Care company. 68 other funds we track also report a position in IRD — the largest reported positions include BIOS Capital Management, LP (US$15.1M), Boxer Capital Management, LLC (US$11.6M), Trails Edge Capital Partners, LP (US$11.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IRD

All IRD fund holders →

FAQ

How long has Caligan Partners LP held IRD?

Caligan Partners LP has disclosed IRD holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Caligan Partners LP's current position in IRD?

As of Q2 2026, Caligan Partners LP holds 6.08M shares of IRD (OPUS GENETICS INC), valued at $24.98M, representing 1.46% of its reported portfolio and ranking #17.

Has Caligan Partners LP been buying or selling IRD?

In the latest 13F filing (Q2 2026), Caligan Partners LP held unchanged its position in IRD.

Which other funds hold IRD?

Other major institutional holders of IRD include BIOS Capital Management, LP, Boxer Capital Management, LLC, Trails Edge Capital Partners, LP, among 68 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.